Webinar :Join Commodity Ki Paathshala on ‘Volatility in Agriculture commodities Prices- Importance of Price Risk Management and Role of Derivatives Markets’ on March 9, 5pm. Register Now!

business

Sanofi backs off from Vatelizumab drug deal with Glenmark

In June 2011, Glenmark had licensed the molecule to Sanofi in a deal worth USD 613 million. This will be a setback to Glenmark‘s plan of launching its own novel biological drug in the market.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections